EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

THE IMPACT OF SUBCLINICAL HYPOTHYROIDISM ON MARKERS OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND ENDOCRINE COMORBIDITIES

Valeriya Nemtsova, Petro Poteiko, Nataliia Ryndina, Vladyslav Berezniakov, Hanna Korchevska, Stanislav Kravchuk

Bulletin of medicine, psychology and pharmacy · 2025

DOI: 10.20998/bmpp.2024.01.05 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of medicine, psychology and pharmacy, 2025. Verfasst von Valeriya Nemtsova und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hypertension (HTN), despite the considerable progress in recent decades, remains a major public health problem and burden worldwide. Purpose of the study to investigate the influence of subclinical hypothyroidism (STH) on the endothelial state in the patients with a comorbid course of HTN and type 2 diabetes mellitus (T2DM). Materials and methods. 240 patients with stage II HTN were divided into 3 groups: group 1 (n = 40) – with isolated HTN, group 2 (n = 120) – with a combined course of HTN and T2DM; group 3 (n = 80) – with comorbidity of HTN, T2DM and SHT. Blood pressure, carbohydrate, lipid and thyroid metabolism, vascular endothelial growth factor (VEGF-A) plasma levels, desquamated circulating endothelial cells (DCEC) were investigated. The results. Patients in all groups experienced dyslipidemia, more pronounced in group 3, but significant difference was shown only for triglycerides (р < 0.05). Blood fasting glucose was significantly higher in group 2 than in group 3 (р < 0.05). The highest levels of VEGF-A were found in the patients with HTN, T2DM and SHT, in the patients with HTN and T2DM, VEGF-A levels were lower than in the patients with isolated HTN. Endothelial morphological changes were the lowest in the group 3 (DCEC levels were 12.06 ± 0.61 cells/100 μl group 1, 11.97 ± 0.31cells/100 μl group 2, 10.07 ± 0.26 cells/100 μl group 3, p1-3 = 0.001 and p2-3 = 0.001, respectively).

Conclusions

The impact of subclinical hypothyroidism on the endothelium is characterised by a progression of impaired vasodilation, but not by morphological damage of the endothelium. Even minor changes in thyroid status contribute to the progression of endothelial dysfunction in patients with comorbid pathology.

Zitieren

APA

Nemtsova, V., Poteiko, P., Ryndina, N., Berezniakov, V., Korchevska, H., & Kravchuk, S. (2025). THE IMPACT OF SUBCLINICAL HYPOTHYROIDISM ON MARKERS OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND ENDOCRINE COMORBIDITIES. Bulletin of medicine, psychology and pharmacy. https://doi.org/10.20998/bmpp.2024.01.05

Vancouver

Nemtsova V, Poteiko P, Ryndina N, Berezniakov V, Korchevska H, Kravchuk S. THE IMPACT OF SUBCLINICAL HYPOTHYROIDISM ON MARKERS OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND ENDOCRINE COMORBIDITIES. Bulletin of medicine, psychology and pharmacy. 2025. doi:10.20998/bmpp.2024.01.05

BibTeX
@article{Nemtsova2025,
  author = {Nemtsova, Valeriya and Poteiko, Petro and Ryndina, Nataliia and Berezniakov, Vladyslav and Korchevska, Hanna and Kravchuk, Stanislav},
  title = {THE IMPACT OF SUBCLINICAL HYPOTHYROIDISM ON MARKERS OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND ENDOCRINE COMORBIDITIES},
  journal = {Bulletin of medicine, psychology and pharmacy},
  year = {2025},
  doi = {10.20998/bmpp.2024.01.05}
}
Kostenlos starten →